CIK 0001802665 · Large accelerated filer
Harmony Biosciences Holdings, Inc.
Sign in to watch- Ticker
- HRMY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822279923
- Phone
- (484) 539-9800
- Business address
- 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,108,586
- in 2 filings
Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-25 | Serafin Andrew CHIEF STRATEGY OFFICER | Grant or award · Restricted Stock Units | +10,400 | 10,400 | ||
| 2025-01-24 | Budur Kumar CHIEF MEDICAL OFFICER | Option exercise | +2,187 | 2,187 | ||
| 2025-01-24 | Budur Kumar CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,151 | $38.01 | $44K | 1,036 |
| 2025-01-24 | Budur Kumar CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −2,187 | 6,563 | ||
| 2025-01-24 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +13,125 | $30.69 | $403K | 13,125 |
| 2025-01-24 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −8,000 | $36.94 | $296K | 5,125 |
| 2025-01-24 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −5,125 | $37.87 | $194K | 0 |
| 2025-01-24 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +2,687 | 2,687 | ||
| 2025-01-24 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Shares withheld for taxes 10b5-1 | −1,058 | $38.01 | $40K | 1,629 |
| 2025-01-24 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise · Stock Option 10b5-1 | −13,125 | 39,375 | ||
| 2025-01-24 | Dierks Jeffrey CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units 10b5-1 | −2,687 | 8,063 | ||
| 2025-01-24 | Dayno Jeffrey M. PRESIDENT, CEO | Option exercise | +10,500 | 10,500 | ||
| 2025-01-24 | Dayno Jeffrey M. PRESIDENT, CEO | Shares withheld for taxes | −4,567 | $38.01 | $174K | 5,933 |
| 2025-01-24 | Dayno Jeffrey M. PRESIDENT, CEO | Option exercise · Restricted Stock Units | −10,500 | 31,500 | ||
| 2025-01-24 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +3,812 | 3,812 | ||
| 2025-01-24 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Shares withheld for taxes 10b5-1 | −2,037 | $38.01 | $77K | 1,775 |
| 2025-01-24 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units 10b5-1 | −3,812 | 11,438 | ||
| 2025-01-24 | Serafin Andrew CHIEF STRATEGY OFFICER | Option exercise | +2,500 | 2,500 | ||
| 2025-01-24 | Serafin Andrew CHIEF STRATEGY OFFICER | Shares withheld for taxes | −865 | $38.01 | $33K | 1,635 |
| 2025-01-24 | Serafin Andrew CHIEF STRATEGY OFFICER | Option exercise · Restricted Stock Units | −2,500 | 7,500 |
Page 7 of 14 · 268 trades